A logo

Agilent Technologies, Inc. (A) EBITDA

annual EBITDA:

$1.85B-$49.00M(-2.58%)
October 31, 2024

Summary

  • As of today (August 22, 2025), A annual EBITDA is $1.85 billion, with the most recent change of -$49.00 million (-2.58%) on October 31, 2024.
  • During the last 3 years, A annual EBITDA has risen by +$162.00 million (+9.60%).
  • A annual EBITDA is now -2.58% below its all-time high of $1.90 billion, reached on October 31, 2022.

Performance

1-year change

-2.58%

3-year change

+9.6%

5-year change

+57.85%

15-year change

+75.52%

A EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

95.9%
A annual EBITDA is higher than 95.9% of companies in Healthcare sector

Range

All-time high

$1.90B
A annual EBITDA is currently -2.58% below its historical high of $1.90 billion

3-year low

$1.69B
A annual EBITDA is currently +9.60% above its 3-year low

Earnings dates

Last annual earnings report date

Oct 31, 2024
A previous annual earnings announcement was published on Oct 31, 2024

Next annual earnings report date

N/A
A next annual earnings announcement has not yet been scheduled

OtherAincome statement metrics

Annual revenue

$6.51B
A annual revenue is $6.51 billion

annual net income

$1.29B
A annual net profit is $1.29 billion

annual EBIT

$1.59B
A annual earnings before interest & taxes is $1.59 billion

Annual EPS

$4.43
A annual earnings per share is $4.43

quarterly EBITDA:

$433.00M-$33.00M(-7.08%)
April 30, 2025

Summary

  • As of today (August 22, 2025), A quarterly EBITDA is $433.00 million, with the most recent change of -$33.00 million (-7.08%) on April 30, 2025.
  • Over the past year, A quarterly EBITDA has increased by +$7.00 million (+1.64%).
  • A quarterly EBITDA is now -79.25% below its all-time high of $2.09 billion, reached on July 31, 1999.

Performance

3-month change

-7.08%

1-year change

+1.64%

3-year change

+1.41%

5-year change

+58.61%

A quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

95.02%
A quarterly EBITDA is higher than 95.02% of companies in Healthcare sector

Range

All-time high

$2.09B
A quarterly EBITDA is currently -79.25% below its historical high of $2.09 billion

3-year low

$426.00M
A quarterly EBITDA is currently +1.64% above its 3-year low

Earnings dates

Last quarterly earnings report date

Apr 30, 2025
A previous earnings announcement was published on Apr 30, 2025

Next quarterly earnings report date

Aug 27, 2025
A next earnings announcement is scheduled for Aug 27, 2025

OtherAincome statement metrics

Quarterly revenue

$1.67B
A quarterly revenue is $1.67 billion

quarterly net income

$215.00M
A quarterly net profit is $215.00 million

quarterly EBIT

$360.00M
A quarterly earnings before interest & taxes is $360.00 million

Quarterly EPS

$0.75
A quarterly earnings per share is $0.75

TTM EBITDA:

$1.86B+$7.00M(+0.38%)
April 30, 2025

Summary

  • As of today (August 22, 2025), A TTM EBITDA is $1.86 billion, with the most recent change of +$7.00 million (+0.38%) on April 30, 2025.
  • Over the past year, A TTM EBITDA has increased by +$24.00 million (+1.30%).
  • A TTM EBITDA is now -70.17% below its all-time high of $6.25 billion, reached on October 31, 1999.

Performance

3-month change

+0.38%

1-year change

+1.3%

3-year change

+4.84%

5-year change

+55.07%

A TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

95.46%
A TTM EBITDA is higher than 95.46% of companies in Healthcare sector

Range

All-time high

$6.25B
A TTM EBITDA is currently -70.17% below its historical high of $6.25 billion

3-year low

$1.84B
A TTM EBITDA is currently +1.30% above its 3-year low

Earnings dates

Last quarterly earnings report date

Apr 30, 2025
A previous earnings announcement was published on Apr 30, 2025

Next quarterly earnings report date

Aug 27, 2025
A next earnings announcement is scheduled for Aug 27, 2025

OtherAincome statement metrics

TTM revenue

$6.63B
A TTM revenue is $6.63 billion

TTM net income

$1.17B
A TTM net profit is $1.17 billion

TTM EBIT

$1.59B
A TTM earnings before interest & taxes is $1.59 billion

TTM EPS

$4.05
A TTM earnings per share is $4.05

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

$1.85B
A annual EBITDA is $1.85 billion

annual net income

$1.29B
A annual net profit is $1.29 billion

annual interest expense

$0.00
A annual interest expense is $0.00

annual income tax

$232.00M
A annual income tax is $232.00 million

annual D&A

$257.00M
A annual depreciation & amortization is $257.00 million

A EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-2.6%+1.6%+1.3%
3 y3 years+9.6%+1.4%+4.8%
5 y5 years+57.9%+58.6%+55.1%

A EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-2.6%+9.6%-14.6%+1.6%-5.1%+1.3%
5 y5-year-2.6%+57.9%-14.6%+40.1%-5.1%+55.1%
alltimeall time-2.6%+312.2%-79.3%+194.3%-70.2%+264.8%

A EBITDA History

DateAnnualQuarterlyTTM
Apr 2025
-
$433.00M(-7.1%)
$1.86B(+0.4%)
Jan 2025
-
$466.00M(-6.2%)
$1.86B(+0.2%)
Oct 2024
$1.85B(-2.6%)
$497.00M(+6.2%)
$1.85B(+0.7%)
Jul 2024
-
$468.00M(+9.9%)
$1.84B(+0.1%)
Apr 2024
-
$426.00M(-7.8%)
$1.84B(-1.9%)
Jan 2024
-
$462.00M(-4.7%)
$1.88B(-2.1%)
Oct 2023
$1.90B(0.0%)
$485.00M(+3.9%)
$1.92B(-0.5%)
Jul 2023
-
$467.00M(+1.1%)
$1.93B(-2.0%)
Apr 2023
-
$462.00M(-8.0%)
$1.97B(+1.8%)
Jan 2023
-
$502.00M(+1.6%)
$1.93B(+1.6%)
Oct 2022
$1.90B(+12.5%)
$494.00M(-2.6%)
$1.90B(+2.1%)
Jul 2022
-
$507.00M(+18.7%)
$1.86B(+4.6%)
Apr 2022
-
$427.00M(-9.3%)
$1.78B(+3.3%)
Jan 2022
-
$471.00M(+3.5%)
$1.72B(+3.5%)
Oct 2021
$1.69B(+33.7%)
$455.00M(+7.1%)
$1.66B(+4.5%)
Jul 2021
-
$425.00M(+14.6%)
$1.59B(+7.9%)
Apr 2021
-
$371.00M(-10.0%)
$1.48B(+7.1%)
Jan 2021
-
$412.00M(+7.6%)
$1.38B(+9.0%)
Oct 2020
$1.26B(+7.8%)
$383.00M(+23.9%)
$1.26B(+5.1%)
Jul 2020
-
$309.00M(+13.2%)
$1.20B(+2.5%)
Apr 2020
-
$273.00M(-8.4%)
$1.17B(+0.4%)
Jan 2020
-
$298.00M(-7.5%)
$1.17B(0.0%)
Oct 2019
$1.17B(+4.9%)
$322.00M(+15.0%)
$1.17B(+2.2%)
Jul 2019
-
$280.00M(+4.5%)
$1.14B(+0.4%)
Apr 2019
-
$268.00M(-10.1%)
$1.14B(+0.3%)
Jan 2019
-
$298.00M(+0.3%)
$1.14B(+0.7%)
Oct 2018
$1.12B(+6.0%)
$297.00M(+8.0%)
$1.13B(+0.9%)
Jul 2018
-
$275.00M(+3.8%)
$1.12B(+2.2%)
Apr 2018
-
$265.00M(-8.6%)
$1.09B(+1.0%)
Jan 2018
-
$290.00M(+1.0%)
$1.08B(+2.9%)
Oct 2017
$1.05B(+7.3%)
$287.00M(+14.3%)
$1.05B(+4.8%)
Jul 2017
-
$251.00M(-1.2%)
$1.00B(+4.0%)
Apr 2017
-
$254.00M(-2.3%)
$965.00M(+6.6%)
Jan 2017
-
$260.00M(+8.8%)
$905.00M(+4.6%)
Oct 2016
$982.00M(+22.4%)
$239.00M(+12.7%)
$865.00M(+2.7%)
Jul 2016
-
$212.00M(+9.3%)
$842.00M(+1.1%)
Apr 2016
-
$194.00M(-11.8%)
$833.00M(+3.9%)
Jan 2016
-
$220.00M(+1.9%)
$802.00M(+5.4%)
Oct 2015
$802.00M(-0.7%)
$216.00M(+6.4%)
$761.00M(+20.2%)
Jul 2015
-
$203.00M(+24.5%)
$633.00M(-4.1%)
Apr 2015
-
$163.00M(-8.9%)
$660.00M(-17.9%)
Jan 2015
-
$179.00M(+103.4%)
$804.00M(-14.8%)
Oct 2014
$808.00M(-41.7%)
$88.00M(-61.7%)
$944.00M(-23.7%)
Jul 2014
-
$230.00M(-25.1%)
$1.24B(-7.3%)
Apr 2014
-
$307.00M(-3.8%)
$1.33B(-4.4%)
Jan 2014
-
$319.00M(-16.3%)
$1.40B(+0.4%)
Oct 2013
$1.39B(-4.3%)
$381.00M(+16.2%)
$1.39B(-0.5%)
Jul 2013
-
$328.00M(-10.9%)
$1.40B(-2.6%)
Apr 2013
-
$368.00M(+17.6%)
$1.44B(+0.8%)
Jan 2013
-
$313.00M(-19.3%)
$1.42B(-1.3%)
Oct 2012
$1.45B(+8.9%)
$388.00M(+6.0%)
$1.44B(+0.7%)
Jul 2012
-
$366.00M(+2.5%)
$1.43B(+1.3%)
Apr 2012
-
$357.00M(+7.5%)
$1.41B(+1.7%)
Jan 2012
-
$332.00M(-12.2%)
$1.39B(+4.1%)
DateAnnualQuarterlyTTM
Oct 2011
$1.33B(+61.7%)
$378.00M(+8.9%)
$1.33B(+8.2%)
Jul 2011
-
$347.00M(+4.2%)
$1.23B(+15.2%)
Apr 2011
-
$333.00M(+20.2%)
$1.07B(+13.1%)
Jan 2011
-
$277.00M(0.0%)
$947.00M(+13.1%)
Oct 2010
$823.00M(+66.6%)
$277.00M(+50.5%)
$837.00M(+13.3%)
Jul 2010
-
$184.00M(-12.0%)
$739.00M(+9.8%)
Apr 2010
-
$209.00M(+25.1%)
$673.00M(+21.7%)
Jan 2010
-
$167.00M(-6.7%)
$553.00M(+10.8%)
Oct 2009
$494.00M(-50.2%)
$179.00M(+51.7%)
$499.00M(-17.9%)
Jul 2009
-
$118.00M(+32.6%)
$608.00M(-20.5%)
Apr 2009
-
$89.00M(-21.2%)
$765.00M(-16.7%)
Jan 2009
-
$113.00M(-60.8%)
$918.00M(-7.5%)
Oct 2008
$992.00M(+26.0%)
$288.00M(+4.7%)
$992.00M(+5.8%)
Jul 2008
-
$275.00M(+13.6%)
$938.00M(+6.5%)
Apr 2008
-
$242.00M(+29.4%)
$881.00M(+6.9%)
Jan 2008
-
$187.00M(-20.1%)
$824.00M(+4.7%)
Oct 2007
$787.00M(+14.9%)
$234.00M(+7.3%)
$787.00M(+6.1%)
Jul 2007
-
$218.00M(+17.8%)
$742.00M(-1.2%)
Apr 2007
-
$185.00M(+23.3%)
$751.00M(+2.0%)
Jan 2007
-
$150.00M(-20.6%)
$736.00M(+3.5%)
Oct 2006
$685.00M(+35.9%)
$189.00M(-16.7%)
$711.00M(-1.8%)
Jul 2006
-
$227.00M(+33.5%)
$724.00M(+15.5%)
Apr 2006
-
$170.00M(+36.0%)
$627.00M(+15.5%)
Jan 2006
-
$125.00M(-38.1%)
$543.00M(+7.7%)
Oct 2005
$504.00M(+1.2%)
$202.00M(+55.4%)
$504.00M(-1.4%)
Jul 2005
-
$130.00M(+51.2%)
$511.00M(-14.8%)
Apr 2005
-
$86.00M(0.0%)
$600.00M(-16.7%)
Jan 2005
-
$86.00M(-58.9%)
$720.00M(-14.2%)
Oct 2004
$498.00M(+5433.3%)
$209.00M(-4.6%)
$839.00M(+0.7%)
Jul 2004
-
$219.00M(+6.3%)
$833.00M(+27.0%)
Apr 2004
-
$206.00M(+0.5%)
$656.00M(+89.6%)
Jan 2004
-
$205.00M(+1.0%)
$346.00M(+3744.4%)
Oct 2003
$9.00M(-101.0%)
$203.00M(+383.3%)
$9.00M(-101.5%)
Jul 2003
-
$42.00M(-140.4%)
-$612.00M(-32.2%)
Apr 2003
-
-$104.00M(-21.2%)
-$903.00M(-7.8%)
Jan 2003
-
-$132.00M(-68.4%)
-$979.00M(-10.2%)
Oct 2002
-$872.00M(-253.3%)
-$418.00M(+67.9%)
-$1.09B(-3.6%)
Jul 2002
-
-$249.00M(+38.3%)
-$1.13B(+10.0%)
Apr 2002
-
-$180.00M(-25.9%)
-$1.03B(+38.2%)
Jan 2002
-
-$243.00M(-47.1%)
-$744.00M(+796.4%)
Oct 2001
$569.00M(-63.7%)
-$459.00M(+214.4%)
-$83.00M(-108.3%)
Jul 2001
-
-$146.00M(-240.4%)
$1.00B(-33.3%)
Apr 2001
-
$104.00M(-75.1%)
$1.51B(-12.4%)
Jan 2001
-
$418.00M(-33.5%)
$1.72B(+9.6%)
Oct 2000
$1.57B(+23.8%)
$629.00M(+76.7%)
$1.57B(+20.1%)
Jul 2000
-
$356.00M(+12.3%)
$1.31B(-57.0%)
Apr 2000
-
$317.00M(+18.7%)
$3.04B(-35.8%)
Jan 2000
-
$267.00M(-27.0%)
$4.73B(-24.3%)
Oct 1999
$1.27B(+17.1%)
$366.00M(-82.5%)
$6.25B(+6.2%)
Jul 1999
-
$2.09B(+3.8%)
$5.88B(+55.0%)
Apr 1999
-
$2.01B(+12.5%)
$3.80B(+112.5%)
Jan 1999
-
$1.79B
$1.79B
Oct 1998
$1.08B(-15.4%)
-
-
Oct 1997
$1.28B
-
-

FAQ

  • What is Agilent Technologies, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for Agilent Technologies, Inc.?
  • What is Agilent Technologies, Inc. annual EBITDA year-on-year change?
  • What is Agilent Technologies, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Agilent Technologies, Inc.?
  • What is Agilent Technologies, Inc. quarterly EBITDA year-on-year change?
  • What is Agilent Technologies, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for Agilent Technologies, Inc.?
  • What is Agilent Technologies, Inc. TTM EBITDA year-on-year change?

What is Agilent Technologies, Inc. annual EBITDA?

The current annual EBITDA of A is $1.85B

What is the all time high annual EBITDA for Agilent Technologies, Inc.?

Agilent Technologies, Inc. all-time high annual EBITDA is $1.90B

What is Agilent Technologies, Inc. annual EBITDA year-on-year change?

Over the past year, A annual EBITDA has changed by -$49.00M (-2.58%)

What is Agilent Technologies, Inc. quarterly EBITDA?

The current quarterly EBITDA of A is $433.00M

What is the all time high quarterly EBITDA for Agilent Technologies, Inc.?

Agilent Technologies, Inc. all-time high quarterly EBITDA is $2.09B

What is Agilent Technologies, Inc. quarterly EBITDA year-on-year change?

Over the past year, A quarterly EBITDA has changed by +$7.00M (+1.64%)

What is Agilent Technologies, Inc. TTM EBITDA?

The current TTM EBITDA of A is $1.86B

What is the all time high TTM EBITDA for Agilent Technologies, Inc.?

Agilent Technologies, Inc. all-time high TTM EBITDA is $6.25B

What is Agilent Technologies, Inc. TTM EBITDA year-on-year change?

Over the past year, A TTM EBITDA has changed by +$24.00M (+1.30%)
On this page